RiverGlades Family Offices LLC Boosts Stock Position in CME Group Inc. (NASDAQ:CME)

RiverGlades Family Offices LLC grew its stake in CME Group Inc. (NASDAQ:CME) by 54.5% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,700 shares of the financial services provider’s stock after acquiring an additional 600 shares during the quarter. RiverGlades Family Offices LLC’s holdings in CME Group were worth $334,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. Vanguard Group Inc. lifted its position in CME Group by 0.6% in the 4th quarter. Vanguard Group Inc. now owns 33,451,194 shares of the financial services provider’s stock valued at $7,044,821,000 after acquiring an additional 215,044 shares in the last quarter. Capital International Investors boosted its position in shares of CME Group by 24.1% during the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after buying an additional 3,069,806 shares during the last quarter. Capital World Investors increased its holdings in CME Group by 8.7% in the 4th quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock worth $3,072,654,000 after buying an additional 1,172,575 shares in the last quarter. Bank of New York Mellon Corp raised its position in CME Group by 2.9% in the 1st quarter. Bank of New York Mellon Corp now owns 6,793,988 shares of the financial services provider’s stock worth $1,462,678,000 after buying an additional 189,842 shares during the last quarter. Finally, Parnassus Investments LLC lifted its stake in CME Group by 0.4% during the 4th quarter. Parnassus Investments LLC now owns 5,667,384 shares of the financial services provider’s stock valued at $1,193,551,000 after acquiring an additional 23,583 shares during the period. 87.75% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on CME shares. Keefe, Bruyette & Woods lifted their price target on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research note on Thursday, July 25th. Piper Sandler reissued an “overweight” rating and set a $225.00 price target on shares of CME Group in a report on Tuesday, August 20th. Deutsche Bank Aktiengesellschaft upped their price objective on CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research report on Thursday, August 15th. Barclays raised their target price on CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 25th. Finally, Bank of America cut shares of CME Group from a “neutral” rating to an “underperform” rating and lowered their price objective for the stock from $212.00 to $177.00 in a research note on Tuesday, September 3rd. Four research analysts have rated the stock with a sell rating, five have assigned a hold rating and three have given a buy rating to the company. According to data from MarketBeat, CME Group presently has a consensus rating of “Hold” and an average price target of $209.73.

Insider Buying and Selling

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the sale, the chief financial officer now directly owns 13,261 shares in the company, valued at approximately $2,877,504.39. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The disclosure for this sale can be found here. 0.30% of the stock is owned by company insiders.

CME Group Stock Down 0.7 %

CME opened at $213.16 on Friday. The stock has a market cap of $76.75 billion, a price-to-earnings ratio of 24.25, a price-to-earnings-growth ratio of 8.85 and a beta of 0.55. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02. The firm’s fifty day moving average is $207.86 and its 200 day moving average is $207.53. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $223.80.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.53 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.53 billion. During the same quarter last year, the business posted $2.30 earnings per share. The firm’s revenue was up 12.7% on a year-over-year basis. On average, sell-side analysts forecast that CME Group Inc. will post 9.94 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th will be issued a $1.15 dividend. This represents a $4.60 annualized dividend and a dividend yield of 2.16%. The ex-dividend date is Monday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 52.33%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.